...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: This so called “Expert Market”

Don't know what to think about the no partner trial Fuzzyjr. The good news is that they should be able to share anything about it as there would be no partner restrictions on news conveyance. At least that is what they have been hiding behind for all the other trials.

tada

 

Share
New Message
Please login to post a reply